查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950528

周邊血管介入器械市場（按器械類型、技術、應用、最終用戶和分銷管道分類），全球預測（2026-2032年）

Peripheral Vascular Interventional Devices Market by Device Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，周邊血管介入器材市場規模將達到 15.2 億美元，到 2026 年將成長至 15.7 億美元，到 2032 年將達到 21 億美元，年複合成長率為 4.68%。

關鍵市場統計數據
基準年 2025 15.2億美元
預計年份：2026年 15.7億美元
預測年份 2032 21億美元
複合年成長率 (%) 4.68%

全面介紹周邊介入器材：重點關注臨床促進因素、手術流程變革、新興技術、健保報銷趨勢與產業策略挑戰

周邊介入器材在現代心血管治療中發揮核心作用，包括動脈和靜脈疾病的血管內治療、透析通路維護以及跨多個專科的栓塞控制。器械工程和手術技術的進步已使許多介入治療從開放性手術轉向微創、影像引導的方式，重新定義了臨床路徑和相關人員的期望。臨床醫師越來越重視那些兼具療效、縮短手術時間、降低併發症發生率以及適用於門診環境的解決方案。

重塑周邊介入治療的關鍵變革包括設備創新、影像和機器人技術、數位整合、門診轉型以及供應鏈演進。

周邊血管治療領域正經歷變革性的轉變，其促進因素包括：技術成熟、手術向門診轉移以及數位醫療融入介入工作流程。器械創新不再局限於材料和設計的漸進式改進，而是擴展到系統層面的提升，例如整合成像、導航輔助和輔助技術，從而降低對操作者的依賴性並減少手術操作的差異性。這些進步正加速被重視可預測臨床結果和高效能個案管理的介入醫師所接受。

評估2025年美國關稅對周邊血管器械供應鏈、定價、採購和商業化策略的累積經濟和營運影響

2025年美國關稅政策的實施，為周邊血管器材生態系統中的製造商、醫療系統和經銷商的運作引入了一個新的變數。進口零件和成品器械關稅導致成本上升，迫使供應商重新評估其籌資策略，在採購合約中實施額外的成本控制措施，並探索其他製造地。這些趨勢將對採購週期產生即時影響，並對產品系列決策產生長期影響。

詳細的細分分析揭示了設備類型、應用領域、最終用戶環境、技術變體和分銷管道選擇如何影響臨床採用和採購趨勢。

對市場區隔的深入理解有助於明確臨床需求、技術能力和商業性機會之間的交集。依器械類型分類，市場涵蓋動脈粥狀硬化斑塊切除術裝置、球囊導管、栓塞劑、栓塞保護裝置、下腔靜脈濾器和支架。在動脈粥狀硬化斑塊切除術裝置中，定向斑塊動脈粥狀硬化斑塊切除術裝置、雷射斑塊動脈粥狀硬化斑塊切除術裝置、軌道動脈粥狀硬化斑塊切除術裝置和旋轉動脈粥狀硬化斑塊切除術裝置等亞型，分別針對特定的病變形態和臨床醫生的偏好，從而影響資本設備決策和臨床培訓需求。球囊導管分為藥物塗層球囊導管和普通球囊導管，藥物塗層球囊導管通常用於血管再阻塞風險高的區域或藥物輸送可減少再次介入治療的區域。栓塞劑分為栓塞彈簧圈、栓塞顆粒和液體栓塞劑，每種栓塞劑都適用於不同的解剖標靶和栓塞策略。另一方面，栓塞保護裝置依手術入路和栓塞風險分為遠端栓塞保護裝置和近端栓塞保護裝置。下腔靜脈濾器分為永久性濾網和可回收濾網。支架則分為裸金屬支架和藥物釋放型支架，這反映了長期通暢性和血管再阻塞控制之間不同的權衡。

美洲、歐洲、中東和非洲以及亞太地區的關鍵區域趨勢將影響採用模式、法規結構、製造在地化和市場進入途徑。

區域趨勢對周邊血管器械的監管預期、採購慣例和創新路徑有顯著影響。在美洲，先進的醫保報銷體系和成熟的介入性心臟病學及放射學生態系統支援新型器械的快速應用。同時，門診手術中心的興起推動了對緊湊高效系統和可靠的上市後證據的需求，以確保對支付方和醫療管理機構課責。北美臨床醫生重視臨床結果數據和手術效率，採購團隊通常優先考慮供應商的可靠性和全面培訓項目。

為醫療器材公司提供策略競爭考察，重點在於創新管線、夥伴關係、在地化生產、售後服務，以及透過臨床證據和結果實現差異化。

醫療設備製造商之間的競爭圍繞著三個相互依存的關鍵挑戰：差異化的臨床性能、可擴展的生產能力和一體化的商業性支援。主要企業正加大對穩健的臨床項目的投入，以產生結果數據，從而支持監管核准和與支付方的談判；同時，透過對醫生培訓和手術支持的補充性投資，降低實施風險。與影像、導航和數位醫療服務提供者的合作，能夠最佳化手術方案規劃和長期結果監測，從而提升產品價值。

為行業領導者提供實用建議，使其研發、生產彈性、定價、證據生成和商業策略與不斷變化的臨床和政策環境保持一致。

致力於在周邊血管介入治療領域中保持並擴大市場佔有率的行業領導者必須系統性地採取策略行動，優先考慮臨床價值、營運柔軟性和商業性敏捷性。首先，他們必須將研發資源集中在能夠降低再次介入治療率和手術複雜性的技術，並輔以嚴謹的臨床試驗，以評估短期療效和長期血管健康狀況。這些證據將有助於醫保報銷談判，並推動相關技術在醫院和門診的普及應用。

採用透明的調查方法，包括識別一手和二手資料來源、臨床醫生訪談、監管分析、供應鏈圖譜繪製以及三角驗證技術，以檢驗結論。

本執行摘要的研究整合了多方面的證據，以確保分析的嚴謹性和實際應用價值。主要依據包括對介入臨床醫生、採購人員和器械工程師的結構化訪談，以及對同行評審的臨床文獻、監管申報文件和操作指南文件的審查。二級資訊來源依據包括器械相關的技術文獻和製造商披露的資訊，以及與臨床試驗註冊庫和專業學會指南的一致性。

策略性結論整合了臨床趨勢、技術轉折點、監管影響以及積極的商業規劃和跨職能協作的必要性。

周邊介入器材市場環境的特徵是創新加速、臨床實踐不斷變化，以及對價值和價值鏈韌性的日益重視。降低血管再阻塞、減少栓塞併發症和實現門診治療等臨床需求正在影響產品開發的優先事項和商業性合作策略。同時，政策變化和貿易趨勢也提升了生產柔軟性和供應商多元化的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 周邊血管介入器械市場（依器械類型分類）

  • 動脈粥狀硬化斑塊切除術裝置
    • 定向斑塊動脈粥狀硬化斑塊切除術裝置
    • 雷射動脈動脈粥狀硬化斑塊切除術裝置
    • 軌道動脈動脈粥狀硬化斑塊切除術裝置
    • 旋轉式動脈粥狀硬化斑塊切除術裝置
  • 球囊導管
    • 藥物塗層球囊
    • 一般球囊導管
  • 栓塞劑
    • 栓塞線圈
    • 栓塞顆粒
    • 液態栓塞劑
  • 栓塞保護裝置
    • 遠端栓塞保護裝置
    • 近端栓塞保護裝置
  • IVC過濾器
    • 永久性下腔靜脈濾器
    • 可回收IVC過濾器
  • 支架
    • 裸金屬
    • 藥物釋放型型

9. 按技術分類的周邊血管介入器材市場

  • 裸金屬
  • 生物可吸收
  • 藥物包衣

第10章 依應用分類的周邊血管介入器材市場

  • 血液透析通路
    • 動靜脈瘻管的維護
    • 移植維持
  • 周邊動脈疾病
    • 嚴重肢體缺血
    • 間歇性跛行
  • 靜脈疾病
    • 慢性靜脈功能不全
    • 深層靜脈栓塞症
    • 靜脈曲張

第11章 周邊血管介入器材市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 周邊血管介入器械市場（依分銷管道分類）

  • 直銷
  • 批發的

13. 周邊血管介入器材市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 周邊血管介入器材市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國周邊血管介入器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國周邊血管介入器材市場

第17章：中國周邊血管介入器材市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • Cordis Corporation
  • Endologix, Inc.
  • InspireMD, Inc.
  • iVascular SLU
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Philips Healthcare
  • Shockwave Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-4F7A6D4FD8BF

The Peripheral Vascular Interventional Devices Market was valued at USD 1.52 billion in 2025 and is projected to grow to USD 1.57 billion in 2026, with a CAGR of 4.68%, reaching USD 2.10 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.52 billion
Estimated Year [2026] USD 1.57 billion
Forecast Year [2032] USD 2.10 billion
CAGR (%) 4.68%

Comprehensive introduction to peripheral vascular interventional devices highlighting clinical drivers, procedural shifts, emerging technologies, reimbursement dynamics, and strategic industry challenges

Peripheral vascular interventional devices occupy a central role in contemporary cardiovascular care, spanning endovascular therapies for arterial and venous disease, dialysis access maintenance, and embolic control across multiple specialties. Advances in device engineering and procedural techniques have shifted many interventions from open surgery to minimally invasive, image-guided approaches, thereby redefining clinical pathways and stakeholder expectations. Clinicians increasingly favor solutions that combine efficacy with shorter procedural times, lower complication rates, and compatibility with outpatient settings.

Demographic and epidemiologic trends have amplified clinical demand, while payers and health systems emphasize value through outcomes measurement and cost containment. In this environment, device developers must reconcile stringent regulatory requirements, evolving reimbursement criteria, and growing expectations for robust real-world evidence. At the same time, innovation cycles have accelerated, with manufacturers iterating on materials, coatings, and delivery systems to address restenosis, embolization risk, and long-term vessel integrity.

Consequently, strategic decision-makers require a consolidated view that integrates clinical drivers, technology trajectories, and commercial imperatives. This introduction frames the subsequent analysis by situating current device modalities within procedural workflows, highlighting the intersection of clinical need and engineering response, and underscoring the importance of cross-functional alignment between clinical affairs, regulatory, market access, and commercial teams.

Critical transformative shifts reshaping peripheral vascular interventions including device innovation, imaging and robotics, digital integration, outpatient migration, and supply chain evolution

The peripheral vascular landscape is undergoing transformative shifts driven by converging forces: technology maturation, procedural migration to outpatient settings, and the integration of digital health into interventional workflows. Device innovation now extends beyond incremental improvements to materials and designs; it encompasses system-level enhancements such as integrated imaging, navigation aids, and adjunctive technologies that reduce operator dependence and procedural variability. These developments accelerate adoption among interventionalists who prioritize predictable clinical outcomes and streamlined case management.

Simultaneously, there is a clear movement toward reducing patient length of stay and expanding case volumes in ambulatory settings. This shift pressures manufacturers to offer compact, user-friendly systems with simplified logistics and strong training support. Digital tools that facilitate remote proctoring, procedural analytics, and longitudinal outcomes tracking are increasingly embedded within commercial models, enabling manufacturers to demonstrate value beyond the point of sale.

Finally, supply chain resilience and manufacturing localization have risen on the strategic agenda. Recent disruptions have prompted industry leaders to reassess sourcing strategies, diversify supplier bases, and consider nearshoring for critical components. Taken together, these shifts redefine competitive boundaries and create windows of opportunity for organizations that can integrate clinical efficacy, operational simplicity, and commercial flexibility into coherent product and market strategies.

Assessment of the cumulative economic and operational impacts of United States tariffs in 2025 on peripheral vascular device supply chains, pricing, sourcing, and commercialization strategies

The imposition of tariffs by the United States in 2025 introduced a new variable into the operational calculus for manufacturers, health systems, and distributors across the peripheral vascular device ecosystem. Tariff-driven cost increases for imported components and finished devices have compelled suppliers to re-evaluate sourcing strategies, layer additional cost-control measures into procurement contracts, and explore alternative manufacturing footprints. These dynamics have immediate implications for procurement cycles and longer-term impacts on product portfolio decisions.

Providers and group purchasing organizations have responded by prioritizing supplier reliability and total-cost-of-ownership analysis, taking into account tariff exposure and logistics volatility. Some manufacturers accelerated efforts to localize production or qualify secondary suppliers in tariff-insulated jurisdictions to preserve pricing competitiveness. Simultaneously, distribution partners adapted inventory management practices to buffer supply for high-acuity devices while seeking contractual protections to manage price fluctuations.

From a strategic perspective, tariffs intensified conversations around modular design and component commonality to reduce dependence on tariff-affected parts. Clinical affairs teams collaborated more closely with supply chain and commercial functions to align product introductions with procurement realities, and regulatory teams assessed the implications of manufacturing shifts on device registrations. Overall, tariffs acted as a catalyst for operational realignment, prompting agile responses that emphasized flexibility, supplier diversification, and closer alignment between manufacturing choices and commercial channels.

In-depth segmentation insights revealing how device type, application area, end user setting, technology variants, and distribution channel choices dictate clinical adoption and procurement dynamics

A granular understanding of segmentation provides clarity about where clinical need, technology capability, and commercial opportunity intersect. Based on Device Type, the landscape encompasses Atherectomy Devices, Balloon Catheters, Embolic Agents, Embolic Protection Devices, IVC Filters, and Stents. Within Atherectomy Devices, the subtypes Directional Atherectomy Devices, Laser Atherectomy Devices, Orbital Atherectomy Devices, and Rotational Atherectomy Devices each address specific lesion morphologies and operator preferences, influencing capital equipment decisions and clinical training requirements. Balloon Catheters distinguish between Drug Coated Balloons and Plain Balloon Catheters, with drug-coated options often positioned where restenosis risk is elevated and where drug delivery can reduce repeat interventions. Embolic Agents are categorized into Embolic Coils, Embolic Particles, and Liquid Embolics, each suited to distinct anatomical targets and embolization strategies, while Embolic Protection Devices are split between Distal Embolic Protection Devices and Proximal Embolic Protection Devices depending on procedural access and embolic risk profile. IVC Filters appear as Permanent IVC Filters and Retrievable IVC Filters, and Stents are characterized as Bare Metal and Drug Eluting, reflecting divergent trade-offs between long-term patency and restenosis management.

Based on Application, treatments address Hemodialysis Access, Peripheral Arterial Disease, and Venous Disease. Hemodialysis Access subdivides into AV Fistula Maintenance and Graft Maintenance, each with different failure modes and device requirements. Peripheral Arterial Disease includes Critical Limb Ischemia and Intermittent Claudication, where treatment goals and acceptable risk thresholds differ markedly. Venous Disease covers Chronic Venous Insufficiency, Deep Vein Thrombosis, and Varicose Veins, which call for distinct therapeutic approaches and device attributes.

Based on End User, utilization patterns diverge across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics, shaping purchasing cycles, capital investment decisions, and service-level agreements. Based on Technology, choices among Bare Metal, Bioabsorbable, and Drug Coated materials influence clinical positioning and regulatory pathways. Finally, Based on Distribution Channel, the dichotomy between Direct Sales and Distributor Sales governs go-to-market complexity, margins, and post-sale service commitments. Synthesizing these segments reveals that device adoption mirrors clinical nuance: devices that address high-acuity, specialized anatomy often require hospital-based adoption supported by training and capital investments, whereas simpler or lower-cost interventions migrate more readily to ambulatory environments. Likewise, technology choices such as drug-coating or bioabsorbability drive evidence generation needs, while distribution decisions affect margin structures and customer intimacy.

Key regional dynamics across the Americas, Europe Middle East and Africa, and Asia-Pacific that influence adoption patterns, regulatory frameworks, manufacturing localization, and market access pathways

Regional dynamics materially influence regulatory expectations, procurement practices, and innovation pathways for peripheral vascular devices. In the Americas, advanced reimbursement frameworks and a mature interventional cardiology and radiology ecosystem support rapid uptake of novel devices, while the rise of Ambulatory Surgical Centers accelerates demand for compact, high-efficiency systems and robust post-market evidence to satisfy payers and administrators. North American clinicians place a premium on clinical outcomes data and procedural efficiency, and procurement teams often prioritize supplier reliability and integrated training programs.

In Europe, Middle East & Africa, heterogeneous healthcare systems and varied reimbursement models create a patchwork of adoption rates. Regulatory harmonization efforts coexist with country-specific procurement practices, prompting manufacturers to tailor market access strategies by jurisdiction. Health systems with constrained budgets emphasize cost-effectiveness and multi-stakeholder value demonstration, while some countries in the region serve as centers of clinical excellence that influence broader practice patterns.

Asia-Pacific presents a dual narrative of rapid demand growth in urban centers alongside persistent affordability and access challenges in lower-income areas. Regional manufacturing ambitions and government incentives have encouraged local production, which in turn affects pricing dynamics and product customization. Clinical practice differences, disease prevalence patterns, and evolving regulatory frameworks make Asia-Pacific a focal point for incremental innovation that balances cost containment with performance. Across all regions, cross-border collaboration and data sharing increasingly shape clinical adoption and regulatory submissions, underscoring the value of region-specific strategies that account for reimbursement, provider preferences, and manufacturing considerations.

Strategic competitive insights into device companies focusing on innovation pipelines, partnerships, manufacturing localization, aftermarket services, and differentiation through clinical evidence and outcomes

Competitive dynamics among device companies center on three interdependent imperatives: differentiated clinical performance, scalable manufacturing, and integrated commercial support. Leading organizations increasingly invest in robust clinical programs that generate outcomes data for regulatory clearance and payer negotiation, while complementary investments in physician training and procedural support help to de-risk adoption. Partnerships with imaging, navigation, and digital health providers extend product value by enabling better procedural planning and long-term outcomes monitoring.

Manufacturing strategy is a second axis of differentiation. Companies that pursue a diversified supplier network or localized production can insulate customers from supply disruption and tariff exposure, thereby strengthening commercial credibility. At the same time, investments in modular platforms and component commonality reduce time-to-market for incremental innovations and improve cost efficiency.

A third strategic focus is aftermarket services and value-added offerings. Extended warranties, outcome-based contracting pilots, and bundled delivery models are increasingly used to create stickiness with healthcare systems. Competitive positioning also reflects portfolio breadth: firms that can offer complementary products across atherectomy, stenting, and embolic control benefit from cross-sell opportunities and stronger system-level value propositions. Ultimately, success depends on aligning clinical evidence generation, operational resilience, and commercial models to meet the nuanced needs of providers and payers.

Actionable recommendations for industry leaders to align research and development, manufacturing resilience, pricing, evidence generation, and commercial strategies with evolving clinical and policy landscapes

Industry leaders seeking to sustain and expand their footprint in peripheral vascular interventions should pursue a coordinated set of strategic actions that prioritize clinical value, operational flexibility, and commercial agility. First, concentrate R&D efforts on technologies that demonstrably reduce repeat interventions and lower procedural complexity, and pair those investments with rigorous clinical programs that capture both short-term efficacy and long-term vessel integrity. This evidence will support reimbursement discussions and facilitate adoption in both hospital and ambulatory settings.

Second, diversify manufacturing and supplier relationships to reduce exposure to trade policy shocks and logistical disruption. Where feasible, qualify regional manufacturing partners and adopt component standardization to streamline regulatory filings and shorten supply chains. Third, evolve commercial models to reflect customer needs: invest in training and remote proctoring to accelerate physician comfort with new devices, and consider outcome-based contracting in select markets to align incentives with health systems.

Fourth, refine distribution strategies by balancing direct sales presence where clinical complexity demands deep engagement with distributor partnerships in geographies where a broad footprint and logistics capability matter more. Finally, integrate digital tools that enhance procedural planning and post-procedural follow-up, using data to demonstrate value to payers and to support quality improvement initiatives. Prioritizing these actions will enable organizations to navigate structural shifts while delivering measurable clinical and economic value.

Transparent research methodology describing primary and secondary data sources, clinician interviews, regulatory analysis, supply chain mapping, and triangulation techniques used to validate conclusions

The research underlying this executive summary synthesizes multiple evidence streams to ensure analytical rigor and practical relevance. Primary inputs include structured interviews with interventional clinicians, procurement leaders, and device engineers, combined with a review of peer-reviewed clinical literature, regulatory filings, and procedural guidance documents. Secondary sources included device-specific technical literature and manufacturer disclosures, which were cross-checked against clinical trial registries and professional society guidelines for consistency.

Analysts employed triangulation techniques to reconcile divergent perspectives and to validate thematic findings. Supply chain and manufacturing assessments relied on supplier audits, trade flow analyses, and discussions with logistics partners to evaluate exposure to policy changes and operational vulnerabilities. Commercial insights were grounded in interviews with hospital purchasing officers, ambulatory surgical center administrators, and distribution channel partners to capture differences in procurement cycles and service expectations.

Quality control measures included independent peer review by clinicians and subject-matter experts, sensitivity testing of strategic assumptions, and explicit documentation of limitations. Where information gaps existed, analysts noted uncertainty and recommended targeted primary research. Ethical considerations guided the handling of proprietary information and clinician disclosures, ensuring that conclusions reflect a balanced and verifiable interpretation of available evidence.

Strategic conclusion synthesizing clinical trends, technological inflection points, regulatory implications, and the imperative for proactive commercial planning and cross-functional alignment

The landscape for peripheral vascular interventional devices is characterized by accelerating innovation, shifting care settings, and heightened scrutiny around value and supply chain resilience. Clinical demands for devices that reduce restenosis, limit embolic complications, and enable outpatient care are shaping product development priorities and commercial engagement strategies. At the same time, policy changes and trade dynamics have elevated the importance of manufacturing flexibility and supplier diversification.

For stakeholders across the value chain, the imperative is to translate clinical differentiation into demonstrable economic value while maintaining operational agility. Organizations that successfully integrate robust clinical evidence, localized or diversified manufacturing, and customer-centric commercial models will be best positioned to capture opportunities as procedural volumes and care models evolve. Cross-functional collaboration among clinical affairs, regulatory, supply chain, and commercial teams is no longer optional; it is a strategic necessity.

In closing, the industry stands at an inflection point where deliberate alignment between product innovation and pragmatic commercialization can accelerate adoption and improve patient outcomes. The path forward requires disciplined evidence generation, strategic operational choices, and a sustained focus on delivering measurable value to providers and payers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Vascular Interventional Devices Market, by Device Type

  • 8.1. Atherectomy Devices
    • 8.1.1. Directional Atherectomy Devices
    • 8.1.2. Laser Atherectomy Devices
    • 8.1.3. Orbital Atherectomy Devices
    • 8.1.4. Rotational Atherectomy Devices
  • 8.2. Balloon Catheters
    • 8.2.1. Drug Coated Balloons
    • 8.2.2. Plain Balloon Catheters
  • 8.3. Embolic Agents
    • 8.3.1. Embolic Coils
    • 8.3.2. Embolic Particles
    • 8.3.3. Liquid Embolics
  • 8.4. Embolic Protection Devices
    • 8.4.1. Distal Embolic Protection Devices
    • 8.4.2. Proximal Embolic Protection Devices
  • 8.5. IVC Filters
    • 8.5.1. Permanent IVC Filters
    • 8.5.2. Retrievable IVC Filters
  • 8.6. Stents
    • 8.6.1. Bare Metal
    • 8.6.2. Drug Eluting

9. Peripheral Vascular Interventional Devices Market, by Technology

  • 9.1. Bare Metal
  • 9.2. Bioabsorbable
  • 9.3. Drug Coated

10. Peripheral Vascular Interventional Devices Market, by Application

  • 10.1. Hemodialysis Access
    • 10.1.1. AV Fistula Maintenance
    • 10.1.2. Graft Maintenance
  • 10.2. Peripheral Arterial Disease
    • 10.2.1. Critical Limb Ischemia
    • 10.2.2. Intermittent Claudication
  • 10.3. Venous Disease
    • 10.3.1. Chronic Venous Insufficiency
    • 10.3.2. Deep Vein Thrombosis
    • 10.3.3. Varicose Veins

11. Peripheral Vascular Interventional Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Peripheral Vascular Interventional Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales

13. Peripheral Vascular Interventional Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Peripheral Vascular Interventional Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Peripheral Vascular Interventional Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Peripheral Vascular Interventional Devices Market

17. China Peripheral Vascular Interventional Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AngioDynamics, Inc.
  • 18.7. Becton, Dickinson and Company
  • 18.8. BIOTRONIK SE & Co. KG
  • 18.9. Boston Scientific Corporation
  • 18.10. C.R. Bard, Inc.
  • 18.11. Cordis Corporation
  • 18.12. Endologix, Inc.
  • 18.13. InspireMD, Inc.
  • 18.14. iVascular S.L.U.
  • 18.15. Lepu Medical Technology Co., Ltd.
  • 18.16. Medtronic plc
  • 18.17. Merit Medical Systems, Inc.
  • 18.18. MicroPort Scientific Corporation
  • 18.19. Penumbra, Inc.
  • 18.20. Philips Healthcare
  • 18.21. Shockwave Medical, Inc.
  • 18.22. Teleflex Incorporated
  • 18.23. Terumo Corporation
  • 18.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED BALLOONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED BALLOONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED BALLOONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PLAIN BALLOON CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PLAIN BALLOON CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PLAIN BALLOON CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PARTICLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PARTICLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PARTICLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LIQUID EMBOLICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LIQUID EMBOLICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTAL EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTAL EMBOLIC PROTECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTAL EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PROXIMAL EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PROXIMAL EMBOLIC PROTECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PROXIMAL EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERMANENT IVC FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERMANENT IVC FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERMANENT IVC FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY RETRIEVABLE IVC FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY RETRIEVABLE IVC FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY RETRIEVABLE IVC FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AV FISTULA MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AV FISTULA MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AV FISTULA MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY GRAFT MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY GRAFT MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY GRAFT MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY INTERMITTENT CLAUDICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY INTERMITTENT CLAUDICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY INTERMITTENT CLAUDICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VARICOSE VEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VARICOSE VEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (U